mardi 16 janvier 2018

Onco Actu du 16 janvier 2018

3.1 Prévention - Tabac

Funding cuts mean stop smoking services can’t offer support [Cancer Research UK]

3.7 Prévention - Alcool

Thangam Debbonaire: ‘The moment I saw the light about alcohol and cancer’ [The Guardian]

3.8 Prévention - Alimentation

Broadcast regulations aren’t enough to protect kids from TV junk food ads [Cancer Research UK]

4.2 Dép., diag. & prono. - Génome

Just Released – Our New Clinical NGS Process Report [enlightenbio]

For Now, Sequencing Cancer Tumors Holds More Promise Than Proof [NPR]

4.5 Dép., diag. & prono. - Colorectal

NHS bowel scope uptake boosted by a fifth when patients sent reassuring reminders [Cancer Research UK]

5.1 Traitements - Pré-clinique

Biologists’ new peptide could fight many cancers [MIT News]

Preclinical study finds Genmab may hold the key to a next-gen triple followup to MEK/BRAF combos [EndPoints]

5.12 Immunothérapies

Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return [FiercePharma]

5.12.7 Immunothérapies - vaccins

Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab [EndPoints]

5.12.8 Immunothérapies - Economie

SMC bars four medicines from NHS [PharmaTimes]

5.2.1 Pharma - Partenariats

Syapse Enters Strategic Collaboration with Roche to Advance Precision Medicine in Oncology [Syapse]

5.3.4 Traitements - AMM (FDA, EMA)

US expands scope of BI’s lung cancer drug Gilotrif [PharmaTimes]

5.5 ASCO

Ipsen announces 13 posters and 1 oral presentation at the 2018 ASCO Gastrointestinal Symposium [Ipsen]

6.10 Politiques

Government should offer assurances of post-Brexit medical radioisotopes supply [Parliament UK]

6.6 Publications

The Next Generation of Discovery – Dimensions [Digital Science]

South Korean universities reach agreement with Elsevier after long standoff [Science]

A New Citation Database Launches Today: Digital Science’s Dimensions [The Scholarly Kitchen]